These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 341142)

  • 1. Is renal osteodystrophy reversible?
    Madsen S; Thaysen JH; Olgaard K; Heerfordt J; Løkkegaard H
    Proc Eur Dial Transplant Assoc; 1977; 14():433-41. PubMed ID: 341142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term evolution of renal osteodistrophy after renal transplantation.
    Alsina J; Gonzalez MT; Bonnin R; Ricart Y; Castelao AM; Gonzalez C; Griñó JM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2151-8. PubMed ID: 2652693
    [No Abstract]   [Full Text] [Related]  

  • 3. Bone scintigraphy in renal osteodystrophy.
    de Graaf P; Schicht IM; Pauwels EK; te Velde J; de Graeff J
    J Nucl Med; 1978 Dec; 19(12):1289-96. PubMed ID: 104017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone disease in patients with long-term renal transplantation and normal renal function.
    Carlini RG; Rojas E; Weisinger JR; Lopez M; Martinis R; Arminio A; Bellorin-Font E
    Am J Kidney Dis; 2000 Jul; 36(1):160-6. PubMed ID: 10873886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone scintigraphy in evaluation of the effect of renal transplantation in patients with renal osteodystrophy].
    Seto K
    Rinsho Hoshasen; 1989 Nov; 34(12):1433-6. PubMed ID: 2593286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone metabolic activity measured with positron emission tomography and [18F]fluoride ion in renal osteodystrophy: correlation with bone histomorphometry.
    Messa C; Goodman WG; Hoh CK; Choi Y; Nissenson AR; Salusky IB; Phelps ME; Hawkins RA
    J Clin Endocrinol Metab; 1993 Oct; 77(4):949-55. PubMed ID: 8408470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative bone scintigraphy in evaluating treatment of renal osteodystrophy.
    De Graaf P; Schicht IM; Te Velde J; Pauwels EK; Kleiverda K; De Graeff J
    Neth J Med; 1983; 26(5):125-9. PubMed ID: 6408495
    [No Abstract]   [Full Text] [Related]  

  • 8. [Determination of bone mineral content and correlations with calciotropic hormones in periodic hemodialysis patients].
    Anelli F; De Maio P; Girardi V; Papagni S; Rossi G; Cantatore FP; Carrozzo M
    Minerva Urol Nefrol; 1992; 44(4):265-73. PubMed ID: 1299008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Subtotal parathyroidectomy in the treatment of renal osteodystrophy in 8 patients under chronic hemodialysis].
    Lillo M
    Rev Med Chil; 1984 Jun; 112(6):564-9. PubMed ID: 6515169
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term experience of alfacalcidol in renal osteodystrophy.
    Sharman VL; Brownjohn AM; Goodwin FJ; Hately W; Manning RM; O'Riordan JH; Papapoulos SE; Marsh FP
    Q J Med; 1982; 51(203):271-8. PubMed ID: 7146311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Whole-body osseous scintigraphy and Ca++ kinetics in patients with renal transplants].
    Roncari G; Quarto Di Palo F; Gastaldi L; Vallino F; Elli A; Polli EE
    Minerva Chir; 1980 May; 35(10):785-9. PubMed ID: 6779237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone scan evidence of renal osteodystrophy in undialyzed uremic patients.
    Smith AJ; Sy W; Lao R
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():130-6. PubMed ID: 756035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution of renal osteodystrophy in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Calderaro V; Oreopoulos DG; Meema HE; Ogilvie R; Husdan H; Khanna R; Quinton C; Murray T; Carmichael D
    Proc Eur Dial Transplant Assoc; 1980; 17():533-42. PubMed ID: 6787584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological, hormonal, biochemical and radiological evaluation of vit. D therapy in osteodystrophy patients on RDT.
    Brancaccio D; Graziani G; Faccini JM; Banfi G; Pedoja G; Watson L
    J Urol Nephrol (Paris); 1976; 82(4-5):359-62. PubMed ID: 940182
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal osteodystrophy in children: the effect of hemodialysis and renal homotransplantation.
    Fine RN; Isaacson AS; Payne V; Grushkin CM
    J Pediatr; 1972 Feb; 80(2):243-9. PubMed ID: 4550451
    [No Abstract]   [Full Text] [Related]  

  • 16. [Serum calcium, phosphorus and alkaline phosphatase as indicators in the therapy of renal osteodystrophy].
    Labos I; Kovacević M
    Med Arh; 1988; 42(4):181-5. PubMed ID: 3270761
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of I,25-dihydroxycholecalciferol in renal osteodystrophy.
    Silverberg DS; Bettcher KB; Dossetor JB; Overton TR; Holick MF; DeLuca HF
    Can Med Assoc J; 1975 Jan; 112(2):190, 193-5. PubMed ID: 1111876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A trial of calcitonin therapy in renal osteodystrophy.
    Delano BG; Baker R; Gardner B; Wallach S
    Nephron; 1973; 11(5):287-93. PubMed ID: 4753519
    [No Abstract]   [Full Text] [Related]  

  • 19. The diagnosis of renal osteodystrophy: a comparison of Technetium-99m-pyrophosphate bone scintigraphy with other techniques.
    Hodson EM; Howman-Giles RB; Evans RA; Bautovich G; Hills EE; Sherbon K; Bach BD; Horvath JS; Tiller DJ
    Clin Nephrol; 1981 Jul; 16(1):24-8. PubMed ID: 6268343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bone scintigraphy in evaluation of the effect of renal transplantation in the patients with renal osteodystrophy].
    Seto K
    Kaku Igaku; 1989 Sep; 26(9):1213-6. PubMed ID: 2810915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.